##gff-version 3
##sequence-region P04792 1 205
P04792	UniProtKB	Chain	1	205	.	.	.	ID=PRO_0000125927;Note=Heat shock protein beta-1	
P04792	UniProtKB	Domain	76	184	.	.	.	Note=sHSP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00285	
P04792	UniProtKB	Region	70	205	.	.	.	Note=Interaction with TGFB1I1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P04792	UniProtKB	Modified residue	12	12	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
P04792	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by MAPKAPK2 and MAPKAPK3;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18088087,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:10383393,ECO:0000269|PubMed:1332886,ECO:0000269|PubMed:8774846;Dbxref=PMID:17081983,PMID:18088087,PMID:18691976,PMID:20068231,PMID:23186163,PMID:24275569,PMID:10383393,PMID:1332886,PMID:8774846	
P04792	UniProtKB	Modified residue	26	26	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P42930	
P04792	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:20068231;Dbxref=PMID:17081983,PMID:20068231	
P04792	UniProtKB	Modified residue	78	78	.	.	.	Note=Phosphoserine%3B by MAPKAPK2%2C MAPKAPK3 and MAPKAPK5;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:10383393,ECO:0000269|PubMed:1332886,ECO:0000269|PubMed:15976317,ECO:0000269|PubMed:1730670,ECO:0000269|PubMed:19166925,ECO:0000269|PubMed:8774846;Dbxref=PMID:20068231,PMID:23186163,PMID:24275569,PMID:10383393,PMID:1332886,PMID:15976317,PMID:1730670,PMID:19166925,PMID:8774846	
P04792	UniProtKB	Modified residue	82	82	.	.	.	Note=Phosphoserine%3B by MAPKAPK2%2C MAPKAPK3 and MAPKAPK5;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:10383393,ECO:0000269|PubMed:1332886,ECO:0000269|PubMed:15976317,ECO:0000269|PubMed:1730670,ECO:0000269|PubMed:19166925,ECO:0000269|PubMed:8774846,ECO:0000269|Ref.14;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:23186163,PMID:24275569,PMID:10383393,PMID:1332886,PMID:15976317,PMID:1730670,PMID:19166925,PMID:8774846	
P04792	UniProtKB	Modified residue	83	83	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:16964243;Dbxref=PMID:16964243	
P04792	UniProtKB	Modified residue	86	86	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
P04792	UniProtKB	Modified residue	98	98	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
P04792	UniProtKB	Modified residue	123	123	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P04792	UniProtKB	Modified residue	174	174	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P04792	UniProtKB	Modified residue	176	176	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P04792	UniProtKB	Modified residue	199	199	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:18691976,PMID:20068231,PMID:23186163,PMID:24275569	
P04792	UniProtKB	Natural variant	7	7	.	.	.	ID=VAR_078128;Note=In HMN2B%3B induces hyperphosphorylation of neurofilaments%3B no effect on cytoplasmic location%3B no effect on dimerization. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28144995;Dbxref=PMID:28144995	
P04792	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_077483;Note=In HMN2B%3B increased aggregation%3B increased homooligomerization%3B changed function in chaperone-mediated protein folding. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22176143,ECO:0000269|PubMed:25965061;Dbxref=PMID:22176143,PMID:25965061	
P04792	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_077484;Note=In HMN2B and CMT2F%3B increased aggregation%3B increased homooligomerization%3B decreased phosphorylation by MAPKAPK2%3B changed function in chaperone-mediated protein folding. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18832141,ECO:0000269|PubMed:22176143,ECO:0000269|PubMed:25965061,ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs557327165,PMID:18832141,PMID:22176143,PMID:25965061,PMID:28144995	
P04792	UniProtKB	Natural variant	41	41	.	.	.	ID=VAR_077485;Note=In HMN2B%3B increased aggregation%3B increased homooligomerization%3B changed function in chaperone-mediated protein folding. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22176143,ECO:0000269|PubMed:25965061;Dbxref=dbSNP:rs1393404971,PMID:22176143,PMID:25965061	
P04792	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_078129;Note=In HMN2B%3B no effect on dimerization%3B no effect on cytoplasmic location%3B no effect on dimerization. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs375244209,PMID:28144995	
P04792	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_077486;Note=In HMN2B%3B decreased homooligomerization%3B decreased heterooligomerization with HSPB6%3B no effect on phosphorylation by MAPKAPK2%3B decreased function in chaperone-mediated protein folding. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18832141,ECO:0000269|PubMed:23948568;Dbxref=dbSNP:rs770272088,PMID:18832141,PMID:23948568	
P04792	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_077487;Note=In HMN2B%3B decreased homooligomerization%3B decreased heterooligomerization with HSPB6%3B no effect on phosphorylation by MAPKAPK2%3B decreased function in chaperone-mediated protein folding. L->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18832141,ECO:0000269|PubMed:23948568;Dbxref=dbSNP:rs121909113,PMID:18832141,PMID:23948568	
P04792	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_018506;Note=In HMN2B%3B decreased homodimerization%3B increased client proteins binding%3B increased function in chaperone-mediated protein folding%3B alters CDK5-mediated phosphorylation of neurofilament proteins and indirectly impairs their anterograde axonal transport. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15122254,ECO:0000269|PubMed:20178975,ECO:0000269|PubMed:23728742,ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs29001571,PMID:15122254,PMID:20178975,PMID:23728742,PMID:28144995	
P04792	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_078130;Note=In HMN2B%3B unknown pathological significance%3B no effect on dimerization%3B no effect on cytoplasmic location%3B no effect on dimerization. Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs558882005,PMID:28144995	
P04792	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_018507;Note=In CMT2F and HMN2B%3B decreased homodimerization%3B increased client proteins binding%3B increased function in chaperone-mediated protein folding%3B alters CDK5-mediated phosphorylation of neurofilament proteins%3B alters CDK5-mediated phosphorylation of neurofilament proteins and indirectly impairs their anterograde axonal transport. S->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15122254,ECO:0000269|PubMed:18832141,ECO:0000269|PubMed:20178975,ECO:0000269|PubMed:23728742;Dbxref=dbSNP:rs28939680,PMID:15122254,PMID:18832141,PMID:20178975,PMID:23728742	
P04792	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_077488;Note=In CMT2F and HMN2B. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22176143;Dbxref=dbSNP:rs863225022,PMID:22176143	
P04792	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_018508;Note=In CMT2F%3B decreased homodimerization only with the wild-type protein%3B increased client proteins binding%3B increased function in chaperone-mediated protein folding. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15122254,ECO:0000269|PubMed:20178975;Dbxref=dbSNP:rs28939681,PMID:15122254,PMID:20178975	
P04792	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_077489;Note=In HMN2B%3B decreased thermal stability%3B changed protein structure%3B changed homooligomerization%3B loss of heterooligomerization with HSPB6%3B decreased function in chaperone-mediated protein folding. R->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18832141,ECO:0000269|PubMed:23643870;Dbxref=dbSNP:rs121909112,PMID:18832141,PMID:23643870	
P04792	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_077490;Note=In HMN2B%3B decreased thermal stability%3B changed protein structure%3B no effect on homooligomerization%3B changed heterooligomerization with HSPB6%3B slightly decreased function in chaperone-mediated protein folding. K->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18952241,ECO:0000269|PubMed:23643870;Dbxref=PMID:18952241,PMID:23643870	
P04792	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_018509;Note=In HMN2B%3B no effect on homodimerization%3B no effect on client proteins binding%3B no effect on function in chaperone-mediated protein folding. T->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15122254,ECO:0000269|PubMed:20178975,ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs28937568,PMID:15122254,PMID:20178975,PMID:28144995	
P04792	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_077491;Note=Rare polymorphism%3B no effect on oligomerization%3B no effect on client proteins binding%3B no effect on function in chaperone-mediated protein folding. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20178975;Dbxref=dbSNP:rs374995963,PMID:20178975	
P04792	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_067085;Note=In CMT2F. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22206013;Dbxref=PMID:22206013	
P04792	UniProtKB	Natural variant	175	205	.	.	.	ID=VAR_078131;Note=In HMN2B. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28144995;Dbxref=PMID:28144995	
P04792	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_077492;Note=In HMN2B%3B unknown pathological significance. T->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20870250,ECO:0000269|PubMed:22176143,ECO:0000269|PubMed:28144995;Dbxref=PMID:20870250,PMID:22176143,PMID:28144995	
P04792	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_018510;Note=In HMN2B%3B decreased protein abundance%3B no effect on oligomerization%3B increased client proteins binding%3B no effect on function in chaperone-mediated protein folding%3B alters CDK5-mediated phosphorylation of neurofilament proteins%3B indirectly impairs their anterograde axonal transport. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15122254,ECO:0000269|PubMed:20178975,ECO:0000269|PubMed:23728742;Dbxref=dbSNP:rs28937569,PMID:15122254,PMID:20178975,PMID:23728742	
P04792	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_078132;Note=In HMN2B%3B formation of large cytoplasmic aggregates%3B no effect on dimerization. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28144995;Dbxref=dbSNP:rs774585320,PMID:28144995	
P04792	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_077493;Note=In CMT2F%3B unknown pathological significance. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22176143;Dbxref=dbSNP:rs772767500,PMID:22176143	
P04792	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_077494;Note=Found in a patient with sporadic amyotrophic lateral sclerosis%3B unknown pathological significance. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27492805;Dbxref=dbSNP:rs764297134,PMID:27492805	
P04792	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Mimicks phosphorylation state%2C leading to dreased ability to act as molecular chaperones%3B when associated with D-78 and D-82. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383393;Dbxref=PMID:10383393	
P04792	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Mimicks phosphorylation state%2C leading to dreased ability to act as molecular chaperones%3B when associated with D-15 and D-82. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383393;Dbxref=PMID:10383393	
P04792	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Mimicks phosphorylation state%2C leading to dreased ability to act as molecular chaperones%3B when associated with D-15 and D-78. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383393;Dbxref=PMID:10383393	
P04792	UniProtKB	Sequence conflict	10	10	.	.	.	Note=L->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04792	UniProtKB	Sequence conflict	109	109	.	.	.	Note=L->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04792	UniProtKB	Sequence conflict	121	121	.	.	.	Note=T->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04792	UniProtKB	Sequence conflict	127	127	.	.	.	Note=R->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04792	UniProtKB	Beta strand	86	88	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4MJH	
P04792	UniProtKB	Beta strand	94	100	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q9P	
P04792	UniProtKB	Turn	102	104	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q9P	
P04792	UniProtKB	Beta strand	107	114	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q9P	
P04792	UniProtKB	Beta strand	117	124	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q9P	
P04792	UniProtKB	Beta strand	136	143	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q9P	
P04792	UniProtKB	Turn	145	147	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2N3J	
P04792	UniProtKB	Helix	150	152	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q9P	
P04792	UniProtKB	Beta strand	154	157	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q9P	
P04792	UniProtKB	Beta strand	161	168	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q9P	
